Movano Health received a notice from Nasdaq regarding the delayed filing of its Quarterly Report on Form 10-Q.
The Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of the Form 10-Q which was due on August 14, 2025.
Movano Health appealed its delisting determination and presented a Compliance Plan to regain compliance with Nasdaq requirements.
Notification of Deficiency
Received notice from Nasdaq due to delayed filing of Form 10-Q.
Compliance Plan
Appealed delisting determination and submitted plan to regain compliance with Nasdaq rules.
Engagement of RBSM LLP
New independent accounting firm engaged for fiscal year 2025.
- Movano Health faces potential delisting from Nasdaq due to non-compliance with filing requirements.
- Uncertainty surrounds the Company's ability to regain compliance and maintain its listing on Nasdaq.
Movano Health's future listing on Nasdaq remains uncertain pending the determination of the Panel. The Company's Compliance Plan and engagement of RBSM LLP are critical steps towards addressing the deficiency and maintaining market presence.